Giovanni Maconi

Plain English
Researchers studied how well symptoms during a lactose breath test (HBT) can predict lactose malabsorption (LM) in 199 adults who had gut issues but no serious diseases. They found that 56.8% of participants had lactose malabsorption, and nearly 85% reported at least one symptom during the test. Flatulence was the most important symptom linked to LM, with those who reported severe symptoms being more likely to have this issue—39.8% compared to only 18.6% of those with milder symptoms. Who this helps: This helps patients with unexplained gastrointestinal issues by guiding better diagnosis and treatment.

Plain English
This review looks at how multiparametric intestinal ultrasound (MPUS) can be used to diagnose and monitor inflammatory bowel diseases (IBD) without needing invasive procedures. It highlights new techniques that help doctors see how the bowel is functioning and to identify problems like inflammation or blockages. Although MPUS shows great promise for improving patient care, challenges like varying techniques and the need for proper training limit its wider use. Who this helps: This benefits patients with inflammatory bowel diseases and their doctors.

Plain English
This study looks at why some people with inflammatory bowel disease (IBD) continue to have belly pain even after their inflammation has gone away. It found that around 40% of these patients experience persistent pain similar to irritable bowel syndrome, likely due to a mix of physical and psychological factors rather than ongoing inflammation. This matters because these symptoms can seriously affect people’s daily lives, and identifying the problem can be challenging. Who this helps: This helps patients with IBD who struggle with chronic pain after their inflammation has resolved.

Plain English
This study looked at how effective a non-invasive imaging technique called transperineal ultrasonography (TPUS) is for detecting and classifying problems around the anus, specifically related to Crohn's disease, like fistulas and abscesses. The findings showed that TPUS has a very high accuracy: for detecting fistulas, it was 97.5%, and for abscess detection, it was 93.5%. This matters because TPUS is easier and safer for patients compared to other methods like MRI or surgery, making it a preferred first step in diagnosis. Who this helps: Patients with Crohn's disease and their doctors.

Plain English
This study looked at ways to prevent acute diverticulitis, a painful condition that affects the colon, in nearly 2,000 patients with newly diagnosed diverticular disease. Researchers followed the patients for three years and found that those on a high-fiber diet had a 5.9% risk of developing the condition, while patients taking mesalamine faced a 9.5% risk, and those on a combination of mesalamine and rifaximin had a 17.1% risk. Notably, mesalamine significantly reduced the risk of diverticulitis in patients with more severe inflammation, showing a 77% to 84% lower risk compared to other treatments. Who this helps: This research benefits patients suffering from diverticular disease by helping doctors choose better treatments to prevent diverticulitis.

Plain English
This study examined whether adding 5-aminosalicylic acid (5-ASA) affects the effectiveness of Janus kinase inhibitors (JAKi) in treating ulcerative colitis (UC). Researchers looked at 633 patients and found that after 48 weeks, 81.3% of those taking both JAKi and 5-ASA achieved remission, compared to 77.0% of those who only received JAKi. The presence of 5-ASA did not significantly change the chances of reaching remission. Who this helps: This information benefits doctors and patients with ulcerative colitis by clarifying treatment options.

Plain English
This study examined how blood flow in specific abdominal arteries relates to gastrointestinal problems in people with systemic sclerosis (SSc), a disease that causes skin and internal tissues to harden. Researchers used Doppler ultrasound to measure blood flow in 78 SSc patients and found that those with certain types of SSc had significantly lower blood flow measurements, indicating more severe conditions. Notably, the study highlighted a link between blood flow in the inferior mesenteric artery and symptoms like fecal incontinence, emphasizing the need for further research into how these vascular issues affect gastrointestinal health in SSc. Who this helps: This helps patients with systemic sclerosis and their doctors by providing insights into managing gastrointestinal complications.

Plain English
This study looked at how a protein called TMEM219 affects stem cells in the intestines of people with Crohn's disease, a serious inflammatory bowel condition. The researchers found that high levels of TMEM219 lead to increased death of these stem cells, which makes it harder for the intestines to heal, especially in patients who do not respond to standard treatments. When they blocked TMEM219 in lab-grown intestinal tissues, the cell's ability to renew itself improved, showing that stopping TMEM219 could help heal the intestines in patients with Crohn’s disease. Who this helps: This research benefits patients with Crohn's disease and their doctors by offering new insights into potential treatments.

Plain English
This research looked at ulcerative colitis, a long-lasting condition that causes inflammation in the lining of the large intestine. The study found that while ulcerative colitis is mainly a disease of the mucosal layer, it can also affect deeper layers of the intestinal wall. Understanding this can help improve treatment strategies, as many patients do not respond to current anti-inflammatory medicines. Who this helps: This helps patients with ulcerative colitis and their doctors.

Plain English
This research paper outlines guidelines for diagnosing and monitoring Inflammatory Bowel Disease (IBD), covering how to accurately diagnose the condition, identify complications, and use monitoring tools effectively. The guidelines emphasize specific needs for patients in different situations, including during pregnancy and after surgery. This is important because proper diagnosis and monitoring can lead to better health outcomes and management for IBD patients. Who this helps: Patients with inflammatory bowel disease and their healthcare providers.

Plain English
This study looked at how effective a method called CT Colonography (CTC) is for assessing patients with inflammatory bowel diseases (IBD), like Crohn's disease and Ulcerative Colitis. It found that CTC is a helpful and less invasive option for evaluating these patients, especially when traditional colonoscopy is not possible, as it can spot complications and provide important details for treatment planning. This matters because using CTC can help doctors make better decisions about the care of IBD patients, potentially improving their health outcomes. Who this helps: This helps patients with inflammatory bowel diseases who cannot undergo traditional colonoscopy.

Plain English
This research studied a new way to take super-detailed images without using labels, by using special fibers that create focused beams of light called photonic nanojets. The researchers found that their setup could clearly see patterns as small as 92 nanometers, which is smaller than what traditional imaging methods can achieve. This is important because it allows for better imaging techniques that can be useful in various fields like medical diagnostics and scientific research. Who this helps: This helps doctors and researchers who need high-resolution imaging for diagnosis and study.

Plain English
This study looked at how changes in bowel movements, like constipation and diarrhea, relate to the severity of diverticular disease (DD) and the risk of acute diverticulitis, a serious complication. Researchers studied 871 patients, finding that 24% had significant constipation and 23% had significant diarrhea. They discovered that worse constipation or diarrhea scores were linked to more severe DD and increased risk of acute diverticulitis, meaning a 1-point increase in bowel issue scores raised the risk by 15% for constipation and 14% for diarrhea. Who this helps: This benefits patients with diverticular disease by helping them understand their symptoms and manage their risk for complications.

Plain English
Researchers studied how many patients with inflammatory bowel diseases (IBD) moved from receiving their medication vedolizumab intravenously (IV) to taking it under the skin (subcutaneously, or SC). Out of 238 patients who were asked to switch, only 9 (or about 3.78%) chose to do so, even though those who switched successfully maintained their health without any side effects. This is significant because it shows that while SC administration can be safe and effective, most patients prefer to stick with IV treatment when they are feeling well. Who this helps: This helps patients with IBD who are currently using IV vedolizumab.

Plain English
This study examined the effectiveness and safety of the drug filgotinib for treating ulcerative colitis (UC) in patients who had already tried other treatments. Out of 102 patients followed for about six months, 46% achieved clinical remission by the end of the study, and those who started filgotinib first had a higher success rate compared to those on second or third lines of therapy. This research is important as it shows that using filgotinib early in treatment can lead to better outcomes with relatively few adverse effects. Who this helps: This benefits patients with ulcerative colitis, particularly those looking for effective treatment options.

Plain English
This study looked at how male and female patients with ulcerative colitis respond to three different treatments: vedolizumab, ustekinumab, and tofacitinib, over a period of 48 weeks. It found that males treated with ustekinumab had better rates of clinical and steroid-free remission at 24 weeks, while females on tofacitinib showed better remission rates at 8 weeks. These findings are important because they can help doctors tailor treatments based on a patient’s sex, improving outcomes for both men and women. Who this helps: This helps patients with ulcerative colitis and their doctors in choosing more effective treatments.

Plain English
This study looks at diverticular disease, a common condition where pouches form in the colon, affecting many people in developed countries. It found that while 20-25% of those with diverticulosis show symptoms, high fiber diets can reduce risk, while smoking and obesity increase it. The report provides clear recommendations for managing this condition, such as using dietary changes instead of routine antibiotics and focusing on individual patient needs for surgery. Who this helps: This helps patients with diverticular disease and their doctors.

Plain English
This study looked at the effectiveness and safety of Upadacitinib (UPA) in treating patients with ulcerative colitis who did not respond to other treatments. Among 202 patients, 45.5% achieved clinical remission at 8 weeks, and by the end of the study, 60.2% were in remission, with 84.6% showing healing in their intestinal lining. The research confirms that UPA is a valuable option for patients with difficult-to-treat ulcerative colitis, with a low rate of serious side effects. Who this helps: Patients with ulcerative colitis who have not had success with other treatments.

Plain English
This study investigated how quickly healthcare trainees can learn to use intestinal ultrasound (IUS) effectively for diagnosing inflammatory bowel disease (IBD). The researchers found that after training, trainees did well with basic skills but needed to complete between 75 to 112 examinations to become proficient in these techniques, with 37.5% to 62.5% of them reaching competency in basic parameters. Advanced skills took longer, with major improvements noted in diagnosing bowel dilation. Who this helps: This benefits patients with inflammatory bowel disease and their doctors by ensuring that proper diagnostic techniques are used in their care.

Plain English
This study looked at how intestinal ultrasound can be used to assess constipation and faecal loading, which is when there is a buildup of stool in the intestines. The research team, made up of experts in gastrointestinal health, found that intestinal ultrasound is a suitable tool for this purpose and identified key ultrasound features, such as the size of the rectum at 30 mm for children, to help diagnose faecal loading. This finding is important because it provides clearer criteria for using ultrasound in diagnosing gastrointestinal issues, improving patient care. Who this helps: This helps patients, especially children with constipation and related gastrointestinal problems.

Plain English
This study looked at how COVID-19 affects people's gut health, particularly those who develop new gut-brain issues after recovering from the virus. Out of 599 patients, 27 (or about 4.5%) developed new gastrointestinal problems, experiencing increased abdominal pain and other symptoms, while others with pre-existing gut issues showed improvements in most symptoms. The findings highlight that those with post-COVID gut issues face ongoing digestive distress and emotional struggles, emphasizing the need for specific treatments for these patients. Who this helps: Patients who developed gastrointestinal issues after COVID-19 and their healthcare providers.

Plain English
This study examined how COVID-19 is linked to the development of irritable bowel syndrome (IBS) by looking at 623 patients over a year. Researchers found that symptoms like difficulty breathing, acid reflux, and hunger pains significantly increased the risk of developing IBS after COVID-19, with some symptoms affecting the risk as much as 3.5 times. Understanding these connections is important because it highlights specific symptoms that can signal a higher risk for IBS, allowing for better treatment and prevention strategies. Who this helps: This helps patients recovering from COVID-19 who may experience digestive issues.

Plain English
This study explored how to identify a specific condition called colonic pseudopolyposis in patients with inflammatory bowel disease (IBD) using a type of ultrasound called intestinal ultrasound (IUS). The researchers found that two key features—colon diameter of at least 12 mm and the presence of blood flow signals—were strongly linked to this condition, achieving a detection accuracy of 75% and a perfect specificity of 100%. This is important because it means that IUS could be an effective tool for monitoring IBD patients for this condition. Who this helps: This helps patients with inflammatory bowel disease and their doctors by providing a reliable method to detect colonic pseudopolyposis.

Plain English
This study looked at how well medical trainees learn to use intestinal ultrasonography (IUS) to examine bowel conditions. It found that both inexperienced and experienced trainees improved their accuracy as they performed more scans, with those who had prior abdominal ultrasound training learning faster. Specifically, they needed to complete at least 84 exams to accurately detect thickened bowel walls and 97 exams to identify serious abdominal complications effectively. Who this helps: This benefits doctors and trainees aiming to improve their ability to diagnose intestinal issues accurately.

Plain English
This research looked at how to define, diagnose, and monitor strictures (narrowed areas) in the small intestine of patients with Crohn's disease using intestinal ultrasound (IUS). The study found that while IUS is generally good at diagnosing strictures, it can't reliably tell the difference between inflammation and scar tissue, which can lead to confusion in treatment. Improving the way we use IUS for these assessments is important because it could lead to better patient care. Who this helps: This benefits patients with Crohn's disease and their doctors by providing clearer guidelines for monitoring their condition.

Plain English
This study looked at how well a special imaging technique called Narrow Band Imaging (NBI) can identify different types of lesions in patients with ulcerative colitis (UC), using three classification systems. They examined 394 lesions and found that the modified Kudo classification was the most accurate, correctly identifying 86% of neoplastic lesions, compared to 71% for the original Kudo and 76% for the NICE classification. This matters because it could improve how doctors monitor and treat patients with ulcerative colitis, reducing the risk of missing important changes in their condition. Who this helps: Patients with ulcerative colitis and their doctors.

Plain English
This study looked at factors related to a specific type of healing in patients with Crohn's disease who have been stable on anti-TNF medications for over a year. Out of 68 patients, 38% achieved full healing of their bowel walls, while more than half had low drug levels, which negatively affected healing. The findings suggest that maintaining proper medication levels and addressing other health conditions can improve healing and outcomes for Crohn's patients. Who this helps: This helps Crohn's disease patients and their doctors by identifying ways to improve treatment effectiveness.

Plain English
This study looked at how changes in diet affect the gut, particularly focusing on the concept of "leaky gut" and using new ultrasound technology to assess the gut's structure and function. Researchers found that existing tests for gut health can be interpreted differently, and they highlighted the need to understand how the gut reacts to stress and dietary changes. By improving our knowledge of how diet affects gut health, this research could lead to more personalized and effective treatments for various gastrointestinal issues. Who this helps: Patients with gut-related conditions and healthcare providers.

Plain English
This research paper reviews how gastrointestinal ultrasound (GIUS) can be used to assess the insides of the gut, particularly for patients with conditions like Crohn's disease and ulcerative colitis. The study highlights that GIUS can help identify changes in the bowel wall and also evaluate what’s inside the intestines, making it useful not only for diagnosing problems but also for guiding treatment. The findings indicate that using GIUS effectively can lead to better diagnostics in patients with various gut issues. Who this helps: This helps patients with gastrointestinal issues and their doctors.

Plain English
This study focused on creating clear definitions and guidelines for identifying and monitoring strictures in the small intestine caused by Crohn's disease using intestinal ultrasound. Experts reached a consensus that a stricture is identified by specific criteria: bowel wall thickness over 3 mm, narrowing of the bowel's opening by more than 50%, and enlargement of the area before the stricture. These new guidelines are important because they standardize how doctors diagnose and measure the effectiveness of treatments for patients with Crohn's disease, ultimately improving care. Who this helps: Patients with Crohn's disease and their doctors will benefit from these clearer diagnostic and treatment monitoring standards.

Plain English
This study looked at the drug ustekinumab (UST) to see how well it works and how safe it is for patients with ulcerative colitis (UC). Researchers followed 256 patients and found that by 24 weeks, 27.6% of them achieved clinical remission, and 61.8% showed a clinical response. The study also noted that only a small number of patients experienced adverse effects (2.3%), which indicates that UST can be a safe and effective option for treating UC. Who this helps: Patients suffering from ulcerative colitis.

Plain English
This study looked at how well the drug ustekinumab (UST) works for patients with Crohn's disease over a long period. Among 562 patients, 80% were in clinical remission after two years, and an impressive 95.4% were in remission after one year of treatment. Only a small number needed surgery (2.1%) or faced other treatment adjustments, showing that UST is generally safe and effective for long-term use. Who this helps: This benefits patients with moderate to severe Crohn's disease seeking effective long-term treatment options.

Plain English
This study looked at how well tofacitinib, a medication for ulcerative colitis (UC), worked in patients who did not respond to previous treatments with anti-TNF drugs. Out of 58 patients, only 6 (10.3%) needed surgery to remove their colon, and many showed improvement in their symptoms after 52 weeks: 53.4% achieved clinical remission, and 50% showed improvement in their colon's condition during follow-up checks. These results are important because they suggest tofacitinib can effectively help patients avoid surgery and manage their UC symptoms. Who this helps: This helps patients with ulcerative colitis who have not responded to anti-TNF treatments.

Plain English
This study looked at how well the medication tofacitinib works for patients with ulcerative colitis in real-life settings in Italy. Researchers found that after 24 weeks, about 45% of patients using tofacitinib achieved clinical remission, and it worked better when used as an initial treatment rather than later, with a significant difference in success rates (36.7% at 8 weeks and 45.2% at 24 weeks). These results are important because they show that using tofacitinib early can lead to better outcomes for patients with this condition. Who this helps: Patients with ulcerative colitis looking for effective treatment options.

Plain English
This study looked at how intestinal ultrasound (IUS) can help doctors understand and predict the long-term effects of Crohn's disease in patients. It found that IUS can reliably determine which patients might respond well to treatment and those at risk for complications or needing surgery. This matters because using IUS could reduce unnecessary procedures and better target treatment plans, potentially improving patient outcomes. Who this helps: This helps patients with Crohn's disease and their doctors.

Plain English
This study looked at the effectiveness of using intestinal ultrasound (IUS) to diagnose inflammatory bowel disease (IBD) in children. Researchers evaluated 113 kids ages 2 to 18 who showed symptoms but didn't have any known diseases. They discovered that signs like thicker bowel walls (more than 3 mm), changes in bowel patterns, and enlarged lymph nodes were good indicators of IBD, with the combined tests being very accurate—achieving 100% specificity, meaning that if the tests were positive, it was nearly certain they had the disease. Who this helps: This benefits children with suspected IBD and their doctors by providing a reliable diagnostic tool.

Plain English
This study looks at Chios mastic gum, a substance used in traditional Greek medicine for over 2,500 years, and examines its potential benefits for inflammatory bowel disease (IBD). Researchers found that mastic gum has anti-inflammatory and antioxidant properties, which might help manage IBD symptoms, though specific numbers weren't provided. Understanding these effects could lead to more focused research and new treatments for IBD in the future. Who this helps: This helps patients with inflammatory bowel disease.

Plain English
This study focused on a woman who had pain in her upper abdomen due to an accessory spleen, a small extra piece of splenic tissue that is found in some people. The doctors used a contrast-enhanced ultrasound to successfully identify the source of her pain, revealing a mass about 1-3 cm in size located in the mesentery, which is the tissue that connects the intestines. This is important because it shows that ultrasound can effectively diagnose this rare condition, which is often missed by other imaging methods. Who this helps: This benefits patients experiencing unexplained abdominal pain and doctors seeking accurate diagnostic tools.

Plain English
This study looked at how common a condition called segmental colitis associated with diverticulosis (SCAD) is among people newly diagnosed with diverticulosis. Out of 2,215 patients, 44 were found to have SCAD, which means it occurs in about 2% of these cases. Those with specific types of SCAD experienced worse symptoms and were less likely to fully recover compared to others. Who this helps: This information is useful for doctors treating patients with diverticulosis to better understand and manage the potential complications.

Plain English
This study looked at how well two assessment methods, DICA and CODA, can predict complications in patients with diverticular disease, and whether measuring fecal calprotectin (FC) can improve those predictions. They followed 871 patients and found that higher levels of FC were linked to a greater risk of acute diverticulitis, specifically with a risk increase of 3.29 times for each tenfold increase in FC concentration within the first three years. While FC can help assess immediate risk of complications, the study suggests using DICA and CODA alone for longer-term treatment strategies, as they were more accurate overall. Who this helps: This research helps doctors better assess and manage patients with diverticular disease.